Table 2.
Multivariate logistic regression analysis for risk factors associated with bone metastasis in cervical patients.
| Variables | OR | 95% CI | P-value |
|---|---|---|---|
| Age* | 0.99 | 0.99, 1.00 | 0.11 |
| Race | |||
| Black | — | — | |
| Other | 0.95 | 0.64, 1.40 | 0.8 |
| Unknown | 0 | 0, 0 | >0.9 |
| White | 1.08 | 0.85 | 0.5 |
| Primary_site | |||
| Cervix uteri | — | — | |
| Endocervix | 0.74 | 0.53, 1.02 | 0.076 |
| Exocervix | 0.3 | 0.05, 0.99 | 0.1 |
| Overlapping lesion of cervix uteri | 0.67 | 0.25, 1.51 | 0.4 |
| Grade | |||
| Gradel | — | — | |
| Gradell | 1.42 | 0.74, 3.00 | 0.3 |
| Gradelll | 1.95 | 1.04, 4.07 | 0.051 |
| GradeIV | 1.74 | 0.81, 4.01 | 0.2 |
| Unknown | 1.77 | 0.95, 3.70 | 0.1 |
| Pathology | |||
| ADC | — | — | |
| Others | 1.11 | 0.81, 1.55 | 0.5 |
| SCC | 0.89 | 0.66, 1.21 | 0.4 |
| SEER_historic | |||
| Distant | — | — | |
| Localized | 0 | 0, 0 | >0.9 |
| Regional | 0 | 0, 0 | >0.9 |
| Unknown | 0.03 | 0, 0.1 | <0.001 |
| Lymph_biopsy | |||
| >4 | — | — | |
| ≤ 3 | 5.03 | 1.70, 14.6 | 0.003 |
| Unknown | 9.22 | 4.82, 20.5 | <0.001 |
| Brain_metastasis | <0.001 | ||
| No | — | — | |
| Unknown | 8.85 | 3.42, 25.0 | <0.001 |
| Yes | 3.28 | 2.02, 5.29 | <0.001 |
| Liver_metastasis | |||
| No | — | — | |
| Unknown | 2.28 | 0.86, 5.72 | 0.085 |
| Yes | 2.66 | 2.10, 3.37 | <0.001 |
| Lung_metastasis | |||
| No | — | — | |
| Unknown | 1.77 | 0.85, 3.52 | 0.11 |
| Yes | 1.6 | 1.30, 1.97 | <0.001 |
| Distant_Lymph_metastasis | |||
| No | — | — | |
| Unknown | 0.02 | 0.03, 0.67 | 0.029 |
| Yes | 6.18 | 3.87, 9.84 | <0.001 |
| CS_tumor_size,cm | |||
| <5 | — | — | |
| ≥5 | 0.84 | 0.04, 5.14 | 0.9 |
| Unknown | 0.98 | 0.79, 1.21 | 0.8 |
*Continuous variable. ADC, Adenocarcinoma; SCC, Squamous cell carcinoma.